Avantor (AVTR)

NYSE Health Care Life Sciences Tools & Services S&P MidCap 400
$15.47
+0.33 (+2.18%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W-3.6%
1M+0.5%
3M+12.7%
6M+86.2%
YTD+35.0%
1Y+33.6%
3Y-11.1%
5Y-61.7%

Key statistics

Full financials →
Market cap$10.5B
P/E (TTM)30.9
EPS (TTM, diluted)$0.50
P/S1.58
P/B1.80
EV / EBITDA15.1
Revenue (TTM)$6.64B
Revenue growth+0.9%
Net margin5.1%
ROE5.8%
Debt / equity0.63
FCF yield4.2%
Dividend yield—
Payout ratio—
Beta (1Y)0.80
Volatility (1Y)42.9%
52-week range$7.26 – $17.45
Avg volume (50D)9.44M

Revenue & net income — last 8 quarters

Statements →
Nov 3, 5:17 PM ET

Avantor grants Chief Legal Officer Claudius Sokenu 62,305 RSUs in special award

Neutral leadership 5.02

Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.

  • Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
  • Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
  • Approved by the Compensation and Human Resources Committee on October 30, 2026
Read the filing on SEC.gov ↗
Oct 28, 6:08 AM ET

Avantor Q3 net sales rise 4.6% to $1,698.3 million; raises 2026 guidance

Positive earnings 2.02

Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% from a year earlier, and returned to year-over-year growth. GAAP diluted EPS was $0.30 versus a loss of $1.04 in the prior-year quarter, which included a $785.0 million goodwill impairment, and the company raised its fiscal 2026 organic revenue growth and free cash flow guidance. Adjusted EPS was flat at $0.22, and adjusted EBITDA fell to $256.9 million from $267.9 million.

  • Net sales $1,698.3 million, up 4.6% (5.2% organic); VWR Distribution & Services organic growth 5.8%
  • GAAP diluted EPS $0.30 vs. $(1.04) a year earlier; adjusted EPS $0.22, unchanged
  • Fiscal 2026 organic revenue growth guidance raised to +0.75% to +1.25% from -0.5% to +0.5%; free cash flow guidance raised to $525 million to $550 million
  • Free cash flow for the quarter was $156.2 million; total gross debt was $3,699.7 million at September 30, 2026
Read the filing on SEC.gov ↗
Sep 21, 7:14 AM ET

Avantor names Todd Garner CFO, effective September 21, 2026, replacing interim CFO Steven Eck

Neutral leadership Written later 5.027.01

Avantor appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026, after he served as CFO of CONMED Corporation from January 2018 until March 2026. Steven Eck, who had been Interim CFO since June 24, 2026, will stop serving as interim CFO and remain Senior Vice President and Chief Accounting Officer, so the filing reports a change in the company's principal financial officer rather than a change in reported results.

  • Todd Garner's annual base salary is $700,000, with a target annual bonus of 80% of base salary and a one-time signing bonus of $150,000.
  • Garner's initial long-term equity grant has a target value of $1,500,000, split evenly between restricted stock units and stock options.
  • Garner will be eligible for a long-term incentive target annual grant of $3,000,000 in future years.
  • Steven Eck will continue as Senior Vice President and Chief Accounting Officer.
Read the filing on SEC.gov ↗
Sep 21, 7:08 AM ET

Avantor names Todd Garner executive vice president and chief financial officer

Neutral leadership Written later 5.027.01

Avantor appointed Todd Garner as executive vice president and chief financial officer, effective September 21, 2026. Garner previously served as CFO of CONMED Corporation from January 2018 until March 2026, and Steven Eck will stop serving as interim CFO while remaining chief accounting officer.

  • Todd Garner, age 57, becomes principal financial officer effective September 21, 2026; he was CFO of CONMED Corporation from January 2018 to March 2026
  • Garner's employment letter, dated September 17, 2026, sets an annual base salary of $700,000 and a target annual bonus of 80% of base salary
  • Garner receives a one-time signing bonus of $150,000 and an initial long-term equity grant with a target amount of $1,500,000
  • Steven Eck ceases to be interim CFO but continues as senior vice president and chief accounting officer
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own AVTR

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $2.98M0.01% Added

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All AVTR congressional trades →
TradedMemberTypeAmount
Aug 13, 2025Gilbert Cisneros CA-31Sell$1,001 – $15,000
Aug 12, 2025Gilbert Cisneros CA-31Sell (partial)$1,001 – $15,000
Jul 23, 2025Gilbert Cisneros CA-31Sell (partial)$1,001 – $15,000
Jun 17, 2025Lisa McClain MI-09Sell (partial)$1,001 – $15,000
Jun 11, 2025Lisa McClain MI-09Buy$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Oct 30Sokenu Claudius
EVP, Chief Legal & Compliance
Award62.30K—$0
Oct 30Hankamer Brittany
EVP, Chief HR Officer
Award46.73K—$0

Prices are end-of-day and split-adjusted. Financial data from Avantor's SEC XBRL filings. Not investment advice.